Role of visfatin chemerin with type two diabetes mellitus

Abstract EN

A cross-sectional study was carried out in Kirkuk city from December 2016 to March 2017.

The number of diabetic patients understudy were 180 whose ages were between 21-81 years old.

These patients admitted to Kirkuk General Hospital and primary health care centers of Kirkuk first health care sector.

The control group who were matched to the diabetic patients studied, included 90 healthy blood donors.

Blood was collected for assessment of HbA1c test, blood glucose level, visfatin and chemerin levels.

The study showed that the highest mean level of visfatin was found in diabetic patients comparing with healthy control ( 6.22±2.17 v.s.

3.54±1.91 ng/ml).

The study showed that the highest mean level of chemerin was found in diabetic patients comparing with healthy control (146.13±12.67 v.s.

92.17±8.01 ng/ml).

The study showed that the highest mean level of visfatin was found in diabetic patients who have elevated level of glucose and HbA1c (5.75±3.81 and 5.91±3.67 ng/ml) respectively, as compared with patients with normal level of glucose and HbA1c (4.61±2.99 and 3.95±2.12 ng/ml) respectively (P: ≤0.05).

The study showed that the highest mean level of visfatin was found in diabetic patients who have elevated level of glucose and HbA1c (148.9±25.7 and 158.6±23.5 ng/ml) respectively, as compared with patients with normal level of glucose and HbA1c (111.5±14.6 and 105.1±15.7 ng/ml) respectively (P: ≤0.05), Table 5 and 6.